Region: Italy
Category: Radiopharmaceuticals
Category: Radiopharmaceuticals
Italy Radiopharmaceuticals
(2 reports matching your criteria)
-
Europe Nuclear Medicine Market, By Type (Diagnostic (SPECT, PET)), Therapeutic (Beta Emitters, Alpha Emitters))); By Application (Diagnostic (SPECT, PET)), Therapeutic (Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Others)); By Procedural Volumes (Diagnostic (SPECT Radiopharmaceuticals, PET Radiopharmaceuticals)), Therapeutic (Beta Emitters, Alpha Emitters, Brachytherapy)); By Country (Germany, United Kingdom, Italy, France, Spain, Belgium, Russia, Netherlands, Rest of Europe), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... By Country (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of MEA), Trend Analysis, Competitive Landscape & Forecast, 2019–2029 Europe Nuclear Medicine Market Size almost Doubles at Robust CAGR of 12.03% during 2023–2029, ... Read More
-
Italy Radiopharmaceuticals Market By Radioisotope (Technetium 99m, Fluorine 18, Iodine I, Gallium 68, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic), By End User (Hospitals and clinics, Medical Imaging centers, Others): Opportunity Analysis and Industry Forecast, 2023-2032
... and Industry Forecast, 2023-2032 The radiopharmaceuticals market in Italy is growing progressively due to the rising demand for radiopharmaceuticals for diagnostics, rehabs, and research study tasks. Radiopharmaceuticals are contaminated medicines that are used in nuclear ... Read More
Research Assistance
